Cofoe Medical Technology Co.,Ltd.
XSEC:301087 주식 보고서
Cofoe Medical TechnologyLtd 대차 대조표 상태 Cofoe Medical TechnologyLtd 의 총 주주 지분은 CN¥4.7B 이고 총 부채는 CN¥847.9M, 이는 부채 대 자기자본 비율을 17.9% 로 가져옵니다. 총자산과 총부채는 각각 CN¥6.5B 및 CN¥1.7B 입니다. Cofoe Medical TechnologyLtd 의 EBIT는 CN¥222.3M 이며 이자보상배율은 -2.6 입니다. CN¥2.7B 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보 이자 보상 비율 -2.6x 현금 CN¥2.66b 주식 CN¥4.75b 총 부채 CN¥1.73b 총 자산 CN¥6.47b
최근 재무 상태 업데이트
모든 업데이트 표시
Third quarter 2024 earnings released: EPS: CN¥0.33 (vs CN¥0.21 in 3Q 2023) Oct 30
Investor sentiment deteriorates as stock falls 16% Oct 15
Upcoming dividend of CN¥0.60 per share Oct 04
New minor risk - Share price stability Sep 30
Cofoe Medical Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 30, 2024 Sep 30
Investor sentiment improves as stock rises 16% Sep 27
Cofoe Medical Technology Co.,Ltd. Approves Interim Dividend for the Year 2024 Sep 20
Cofoe Medical Technology Co.,Ltd. Announces the Profit Distribution Proposal for the First Half of 2024 Aug 31
Second quarter 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.30 in 2Q 2023) Aug 30
Cofoe Medical Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 30, 2024 Jun 29 Cofoe Medical Technology Co.,Ltd. Announces Final Dividend of A Shares for 2023, Payable on 12 June 2024 Jun 06
New major risk - Revenue and earnings growth May 18
New major risk - Dividend sustainability May 09 Cofoe Medical Technology Co.,Ltd., Annual General Meeting, May 20, 2024 Apr 30
Cofoe Medical Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 29, 2024 Mar 30
Investor sentiment deteriorates as stock falls 17% Feb 05
Cofoe Medical Technology Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 29, 2024 Dec 30
Third quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.18 in 3Q 2022) Nov 01
Cofoe Medical Technology Co.,Ltd. to Report Q3, 2023 Results on Oct 30, 2023 Sep 30
Second quarter 2023 earnings released: EPS: CN¥0.30 (vs CN¥0.38 in 2Q 2022) Aug 30
Cofoe Medical Technology Co.,Ltd. Approves Profit Distribution Plan for 2022, Payable on 25 May 2023 May 20
Cofoe Medical Technology Co.,Ltd. Approves Profit Distribution Plan for 2022 May 18
Investor sentiment improves as stock rises 15% May 02
First quarter 2023 earnings released: EPS: CN¥0.65 (vs CN¥0.24 in 1Q 2022) Apr 26
Cofoe Medical Technology Co.,Ltd. Approves Board Elections Jan 19
Investor sentiment deteriorated over the past week Dec 19
Investor sentiment improved over the past week Nov 30
Less than half of directors are independent Nov 16
Investor sentiment improved over the past week Nov 04
Third quarter 2022 earnings released: EPS: CN¥0.18 (vs CN¥0.57 in 3Q 2021) Oct 27
Second quarter 2022 earnings released: EPS: CN¥0.38 (vs CN¥0.55 in 2Q 2021) Aug 29
Investor sentiment improved over the past week Jul 02
Insufficient new directors Jun 15
재무 상태 분석
단기부채: 301087 의 단기 자산 ( CN¥4.0B )이 단기 부채 ( CN¥1.4B ).
장기 부채: 301087 의 단기 자산( CN¥4.0B )이 장기 부채 ( CN¥301.0M ).
부채 대 자본 내역 및 분석
부채 수준: 301087 총 부채보다 더 많은 현금을 보유하고 있습니다.
부채 감소: 301087 의 부채 대 자기자본 비율은 지난 5년간 13% 에서 17.9% 로 증가했습니다.
부채 범위: 301087 의 부채는 영업 현금 흐름 ( 54.2% )에 의해 잘 충당 되었습니다.
이자 보장: 301087 지불하는 것보다 더 많은 이자를 벌기 때문에 이자 지불 보장은 문제가 되지 않습니다.
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}